April 16 (Reuters) - Mithra Pharmaceuticals SA MITRA.BR :
* MAYNE PHARMA SUBMITS NEW DRUG APPLICATION FOR E4/DRSP TO FDA
* IF APPROVED BY FDA, E4/DRSP IS EXPECTED TO BE MADE AVAILABLE TO PATIENTS IN US MARKET IN FIRST HALF OF CALENDAR 2021
* MAYNE PHARMA GROUP LIMITED AND MITHRA PHARMACEUTICALS SA TODAY ANNOUNCE THAT MAYNE PHARMA HAS SUBMITTED NEW DRUG APPLICATION (NDA) TO FDA, SEEKING MARKETING AUTHORISATION FOR E4/DRSP